| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff0c7a639b3feb8bead26169e87cd410 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D251-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 |
| filingDate |
2020-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42951a30203f4f86a565fb2d98a3d52b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3853c0e64d388c9ae91fe483a1653fd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6db0f43576be43f2e8ec4567013e70b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_655b078c515d4b62909551857e688434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b926a1e07d2d8920dedd9cea5f6a407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_819ba2aee6aeeadcaedcf0c31cf1fab3 |
| publicationDate |
2020-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020176741-A9 |
| titleOfInvention |
Azacitidine and its derivatives for the treatment of multiple sclerosis |
| abstract |
Provided are methods of treating multiple sclerosis, which comprises administering to a patient a therapeutically effective amount of DNA methylation blocker. Also provided are method of retarding development of multiple sclerosis by administering to a patient a therapeutically effective amount of DNA methylation blocker. |
| priorityDate |
2019-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |